Cancer Researcher Donald Pinkel Dies at Age 95

Unsatisfied by how treatments for childhood leukemia failed to prevent the disease’s return, Pinkel combined them all—and virtually cured the disease.

Written byNatalia Mesa, PhD
| 3 min read
A man in lab coat sitting at lab bench looking at a small stoppered beaker.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Donald Pinkel, a pediatrician who revolutionized the treatment for a once-deadly form of childhood leukemia, died last Wednesday (March 9) in his home in San Luis Obispo, California, at the age of 95.

St. Jude Children’s Research Hospital, Pinkel’s long-time place of work, announced his death but did not give a specific cause, reports The Washington Post.

Pinkel was born in Buffalo, New York, in 1926 to Anne and Lawrence Pinkel. In 1944, he joined the Navy, and then went to Cornell University as part of the service’s V-12 program, reports The New York Times. He finished his undergraduate degree at Canisius College in Buffalo, then went to medical school at the University of Buffalo, defraying some of the cost by joining the Army Reserve Medical Command, and earned his degree in 1951. Pinkel specialized in pediatrics, finding his niche in childhood cancer. He completed a series of residencies before ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies